Healthdyne shareholders to decide in late July:
This article was originally published in Clinica
Healthdyne, the target of a hostile takeover offer from Invacare, will hold its annual shareholder meeting on July 30th. By this time second-quarter results will be available, which Healthdyne expects will demonstrate to shareholders the success of its strategies before they vote on Invacare's offer. In the first quarter, Healthdyne reported a 30% increase in sales to $36 million. Invacare's offer stands at $13.50 a share but Healthdyne's shares closed at $14.25 on April 24th.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.